NCT02942342View on ClinicalTrials.gov

Evaluation of Asymptomatic Coronary Atherosclerotic Disease Among People of Kalamazoo, MI

NAUnknownINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

January 31, 2022

Study Completion Date

March 31, 2022

Conditions
Coronary Artery DiseaseAtherosclerosis
Interventions
PROCEDURE

Computed Tomography (CT) Scan

CT Scans will be used as a diagnostic tool for asymptomatic CAD.

Trial Locations (1)

49080

RECRUITING

Borgess Medical Center, Kalamazoo

Sponsors
All Listed Sponsors
lead

Borgess Research Institute

OTHER

NCT02942342 - Evaluation of Asymptomatic Coronary Atherosclerotic Disease Among People of Kalamazoo, MI | Biotech Hunter | Biotech Hunter